Navigation Links
New prostate cancer imaging shows real-time tumor metabolism
Date:11/29/2010

oncologist with the UCSF Helen Diller Family Comprehensive Cancer Center who is leading the clinical aspects of the current study.

More than 200,000 men are diagnosed with prostate cancer each year and 28,000 die from it, making it one of the most common cancer in men nationwide and also one of the leading causes of cancer death in men, according to the Centers for Disease Control.

Yet the disease ranges widely in its rate of growth and aggressiveness, according to John Kurhanewicz, PhD, a UCSF expert in prostate cancer imaging. As a result, there is great debate over the ideal strategy for treating the disease, he said, leaving patients with a difficult and potentially life-changing decision over how aggressively to respond to the disease.

"This test could give both physicians and patients the information they need to make that decision," said Kurhanewicz, whose work with Dan Vigneron, PhD, and their colleagues from the UCSF Department of Radiology and Biomedical Imaging first linked a prostate tumor's production of lactate to tumor aggressiveness. Other researchers also have linked that lactate production to tumor aggressiveness and response to therapy in other cancers.

The method uses compounds involved in normal tissue function in this case, pyruvate, which is a naturally occurring by-product of glucose, and lactate, also known as lactic acid and uses newly developed equipment to increase the visibility of those compounds by a factor of 50,000 in a magnetic resonance imaging (MRI) scanner.

That process requires pyruvate to be prepared in a strong magnetic field at a temperature of minus 272O C, then rapidly warmed to body temperature and transferred to the patient in an MRI scanner before the polarization decays back to its native state.

The result is a highly defined and clear image of the tumor's outline, as well as a graph of the amount of pyruvate in the tumor and the rate at which the tumor converts
'/>"/>

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Prostate cancer clinical stage does not predict recurrence
2. Medicare Panel Endorses Vaccine for Prostate Cancer Patients
3. New drug targets vitamin D receptors in hormone resistant prostate cancers
4. Multidisciplinary approach is key to successful treatment of aggressive prostate cancer
5. Prostate cancer treatment linked to higher rate of colon cancer, study finds
6. Colorectal cancer risk increases in prostate cancer patients on androgen deprivation therapy
7. Could a Prostate Cancer Treatment Raise Colon Cancer Risk?
8. Fracture Risk Seen With Hormone Therapy for Prostate Cancer
9. Use of Prostate Cancer Treatment Fell When Medicare Paid Docs Less
10. Scientists develop method to keep surgically-removed prostate tissue alive and working for week
11. Prognostic markers for prostate cancer patients who receive radiation after surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... York, New York (PRWEB) , ... July 31, 2015 , ... ... to strut their stuff, Super-Sod debuted their new type of sod called Leisure ... registered trademark application in process. , To commemorate introduction of this new type of ...
(Date:7/31/2015)... ... ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on ... Super Bowl. In the two weeks that separate the conference championships and the Super Bowl, ... Bowl game will mark the 50th time it has been held and the festivities will ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s only ... was also the first provider of Exilis non-surgical fat reduction in New York. ... has attracted a large International clientele. Many patients travel to New York to ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... new store run by GoodThreads. The store can be accessed by visiting ... many of which are customizable. The best part: whenever a product is purchased, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade ... outer thighs. The original applicator required a 2 hour treatment time. The ...
Breaking Medicine News(10 mins):Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3
... Philadelphia, PA Louis J. Soslowsky, Ph.D. Fairhill ... director of the McKay Orthopaedic Research Laboratory and ... of Pennsylvania School of Medicine, was named the ... Delta Award by the American Academy of Orthopaedic ...
... ... at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein ... , ... (Vocus) March 10, 2010 -- An experimental thyroid drug reduces cholesterol without the troublesome ...
... ... Improves Team Collaboration and Efficiency , ... San Francisco, CA (PRWEB) March 10, 2010 -- Manymoon announced today ... in the Google Apps Marketplace™, Google,s recently launched online storefront for Google Apps™ products ...
... , ... , ... ... ANN ARBOR, Mich. , March 10 Many Americans will lose an hour of sleep on March 14 ...
... Discovery in mouse study may someday extend men,s lives, ... therapy has proven useful in treating late-stage prostate cancer, ... tumors that are resistant to such therapy. , Now, ... a mechanism by which the secondary tumors gain their ...
... ... Recognized for PrescriptionDrugs.com Business Plan , ... Boston, MA (PRWEB) March 11, 2010 -- A week from today, ... ever HBS Alumni New Venture Contest . PrescriptionDrugs.com co-founder Mike “Zappy” Zapolin will ...
Cached Medicine News:Health News:Penn researcher, Louis J. Soslowsky, PhD, winner of the AAOS Kappa Delta Ann Doner Vaughan Award 2Health News:Penn researcher, Louis J. Soslowsky, PhD, winner of the AAOS Kappa Delta Ann Doner Vaughan Award 3Health News:Thyroid Hormone Analogue for Treating High Cholesterol 2Health News:Thyroid Hormone Analogue for Treating High Cholesterol 3Health News:Manymoon Now Available Through the Google Apps Marketplace 2Health News:Manymoon Now Available Through the Google Apps Marketplace 3Health News:Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says 2Health News:Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says 3Health News:Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says 4Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 3Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 2Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 3
(Date:7/30/2015)... -- Amgen (NASDAQ: AMGN ) today announced the appointment of ... Pincus LLC, to the Amgen Board of Directors. ... and the deep, global experience he brings in the biopharmaceuticals ... , chairman and chief executive officer of Amgen. "Fred,s breadth of ... Mr. Hassan has been Partner and Managing Director ...
(Date:7/30/2015)...  Cleveland Clinic President Wael Barsoum , M.D. ... that industry is compelled to adopt declining reimbursements throughout ... develop the transformational innovations -- required to thrive in ... by Doug Kohrs , past President and CEO ... that industry must add "episode of care," also known ...
(Date:7/30/2015)... July 30, 2015  Growth of the U.S. nonprescription ... bring former prescription users to the OTC market. Due ... forecasts robust Rx-to-OTC switch activity over the next five ... with many new brands entering the market into existing ... next five years (even those with low to moderate ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... 15 Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), ... the sale of 4,229,000 of its common shares to Commerce ... approximately $6.3 million , or approximately $1.49 ... Commerce Court.  Poniard intends to use the approximately $6.1 ...
... 15 At this year,s annual meeting of ... in Atlanta , Royal Philips Electronics ( ... cardiology patient care by highlighting a range of technology ... intuitive information management systems, new temperature modulation therapies, solutions ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces $6.3 Million Financing 2Poniard Pharmaceuticals Announces $6.3 Million Financing 3Poniard Pharmaceuticals Announces $6.3 Million Financing 4Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 2Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 3Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 4Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 5Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 6Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 7Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 8Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 9
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: